Scrip

J.P. Morgan Conference Updates

By Mandy Jackson 22 Jan 2020

Updates and coverage of the 2020 J.P. Morgan Healthcare Conference in San Francisco.

Topic Business Strategies Deals Launches Reimbursement

Scrip

Novartis Sees Reimbursement Advantage For PCSK9 Launch

By Jessica Merrill 28 Nov 2019

Administration under the medical benefit/Medicare Part B could mean easier reimbursement. The company outlined early plans for the launch of inclisiran after announcing it will buy The Medicines Company for $9.7bn.

Topic Business Strategies Deals Reimbursement

Pink Sheet

Goodbye CFDA, Hello MRA: China Overhauls Regulatory Bodies

By Brian Yang 20 Mar 2018

China proposes to merge its top drug regulator into new combined body, and creates a medical reimbursement agency in move viewed as sign of strengthening regulatory oversight.

Topic Reimbursement Drug Review

Medtech Insight

NEST Coordinating Center At Year One: Device Data-Sharing Network In Its Sights

By Ferdous Al-Faruque 30 Jan 2018

A year after the NEST Coordinating Center was launched, the group has expanded its staff.

Topic Reimbursement

Medtech Insight

Lingering Debt And New E-Procurement System Await Turkish Medtech

By Ahmet Sevindik 18 Jan 2018

2017 saw developments that were beneficial to the Turkish medtech industry, like the continued progress of the billion-dollar City Hospitals project.

Topic Reimbursement

Pink Sheet

OMB's Grogan Talks Drug Pricing And Taking On 'Sacred Cows'

By Cathy Kelly 16 Nov 2017

Concerns with promoting competition and reducing consumers' 'pain in the pocketbook' are key tenets of the Trump Administration's approach. 

Topic Reimbursement

Medtech Insight

New UK Pathway To Cut Access Times For Breakthrough Products By Up To Four Years

06 Nov 2017

The government’s much heralded response to the UK’s Accelerated Access Review backs proposals such as an accelerated pathway.

Topic Reimbursement

Topic Reimbursement

Datamonitor Healthcare

Inside the payer perspective market

07 Jun 2017

Market Access & Reimbursement: Inside the Payer Perspective on Multiple Myeloma

Topic Reimbursement